Stock CVKD CADRENAL THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Static Chart Cadrenal Therapeutics, Inc.

Equities

CVKD

US1276361086

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-28 pm EDT 		5-day change 1st Jan Change
0.47 USD +3.21% Intraday chart for Cadrenal Therapeutics, Inc. +4.03% -36.48%
May. 09 Cadrenal Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 09 Cadrenal Therapeutics Receives FDA Orphan Drug Designation for Tecarfarin for Prevention of Thromboembolism and Thrombosis in Patients with LVADs, RVADs, Biventricular Assist Devices, and Total Artificial Hearts CI
Chart Cadrenal Therapeutics, Inc.
  1. Stock Market
  2. Equities
  3. CVKD Stock
  4. Charts Cadrenal Therapeutics, Inc.
  5. Static Chart